Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Charles Kelly.

Newcastle AuthorsTitleYearFull text
Dr Charles Kelly
Are taxanes more effective than 5FU in combination chemotherapy for recurrent and metastatic head and neck cancer?2022
Dr Chang Lee
Dr Charles Kelly
Mani Ragbir
Daniel Saleh
Postoperative radiotherapy delay in head and neck cancer patients undergoing major resection and free flap reconstruction2022
Nick West
Neil Richmond
David Morgan
Professor Vinidh Paleri
Dr Charles Kelly
et al.
A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer2021
James O'Hara
David Hamilton
Dr David Meikle
Dr Charles Kelly
Professor Vinidh Paleri
et al.
Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma—A large observational single-centre series from the United Kingdom2021
Dr Charles Kelly
Response to “Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma”—Does it require to irradiate neck in pN0 disease?2021
Professor Vinidh Paleri
Dr Charles Kelly
De-intensification of treatment in human papilloma virus related oropharyngeal carcinoma: Patient choice still matters for de-escalation and for the COVID era2020
Mohammad Iqbal
Dr Charles Kelly
Is it Time to Have a Further Debate on Separating Radiation and Medical Oncology Specialties Rather than Continue the Clinical Oncology Model?2019
Dr Charles Kelly
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: Survival analysis of the AVAST-M trial2018
Dr David Meikle
Dr Charles Kelly
Professor Vinidh Paleri
James O'Hara
Contralateral neck metastases in lateralised, resectable advanced stage oropharyngeal squamous cell carcinoma—Results of 57 patients undergoing bilateral selective neck dissection2018
Dr Charles Kelly
Dr Michael Drinnan
Professor Vinidh Paleri
Extreme long-term voice outcomes after concurrent chemoradiotherapy for advanced non-laryngeal head and neck cancer: Eight-year post-treatment analysis2018
Dr Charles Kelly
Dr Hazel McCallum
Dr Rachel Pearson
Guidelines & recommendations: UK quantitative WB-DWI technical workgroup: Consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer2018
Dr Charles Kelly
Bojidar Goranov
David Morgan
Professor Vinidh Paleri
Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A survey of UK national practice2018
Dr Charles Kelly
Bojidar Goranov
Professor Vinidh Paleri
Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review2018
Dr Hans Sathasivam
James O'Hara
Dr David Meikle
Dr Charles Kelly
Dr Max Robinson
et al.
Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer2018
Dr Charles Kelly
Small cell neuroendocrine carcinoma of the alveolar process of maxilla2018
JJ Wyatt
Dr Charles Kelly
Dr Hazel McCallum
Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging–Only Radiation Therapy2018
JJ Wyatt
Dr Charles Kelly
Dr Hazel McCallum
Investigating the generalisation of an atlas-based synthetic-CT algorithm to another centre and MR scanner for prostate MR-only radiotherapy2017
Dr Charles Kelly
Chemotherapy: United Kingdom National Multidisciplinary Guidelines2016
Professor Vinidh Paleri
Dr Charles Kelly
Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate2015
Professor Vinidh Paleri
Dr Charles Kelly
Small cell neuroendocrine carcinoma of larynx: Case series and literature review2015
Professor Vinidh Paleri
Dr Alastair Greystoke
Dr Charles Kelly
Spindle cell carcinoma of the head and neck region: Treatment and outcomes of 15 patients2015
Dr Charles Kelly
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study2014
Dr Joanne Patterson
Professor Elaine McColl
Professor Paul Carding
Anthony Hildreth
Dr Charles Kelly
et al.
Swallowing in the first year after chemoradiotherapy for head and neck cancer: Clinician- and patient-reported outcomes2014
Dr Ross Maxwell
Dr John Wilsdon
Dr Charles Kelly
Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study2012
Professor Vinidh Paleri
Professor Paul Carding
Dr Sanjoy Chatterjee
Dr Charles Kelly
Emerita Professor Janet Wilson
et al.
Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: A prospective study2012
Dr Sanjoy Chatterjee
Dr John Wilsdon
Dr Judith Mott
Paddy Stevenson
Dr Ross Maxwell
et al.
Final Results of Vortigern Study: CT Versus Pet-CT Based Tomotherapy Voluming and Dose Escalation in Oropharyngeal Squamous Cell Carcinoma (ISRCTN 33175361, UKCRN ID: 08/h0907/127) [meeting abstract]2011
Dr Charles Kelly
Professor Vinidh Paleri
Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer2010
Dr Sanjoy Chatterjee
Dr John Wilsdon
Dr Judith Mott
Paddy Stevenson
Dr Ross Maxwell
et al.
VortigERN: Variation of radiotherapy target volume definintion, dose to organs at risk (OAR), and clinical target volumes using anatomic (CT)versus combined anatomic and molecular imaging (PET-CT): Intensity-modulated radiotherpay delivered using a tomotherapy hi art machine2010
Dr Shaheel Chummun
Neil McLean
Dr Charles Kelly
Mucoepidermoid carcinoma of the head and neck: A 13-year review2008
Dr Charles Kelly
Radiotherapy for management of skin cancers in fibrodysplasia ossificans progressiva: A case report and review of the literature2008
Professor Vinidh Paleri
Dr Charles Kelly
Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: A decision analysis model based on a systematic review2008
Dr Charles Kelly
Andrew Welch
Professor Vinidh Paleri
The effect of comorbidity on quality of life during radiotherapy in head and neck cancer2008
Professor Vinidh Paleri
Dr Nick Steen
Dr Charles Kelly
Comorbidity in nasopharyngeal carcinoma: A preliminary communication on the prevalence, descriptive distribution and impact on outcome2007
Professor Vinidh Paleri
Dr Nick Steen
Dr Charles Kelly
Comorbidity in nasopharyngeal carcinoma: a preliminary communication on the prevalence, descriptive distribution and impact on outcome2007
Dr Charles Kelly
Professor Vinidh Paleri
Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer2007
Dr Charles Kelly
Neil McLean
Carcinoma ex benign pleomorphic adenoma of the parotid gland2005
Dr Nicholas Jakubovics
Dr Charles Kelly
Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands2005
Dr Nicholas Jakubovics
Dr Charles Kelly
Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors2005
Dr Charles Kelly
Neil McLean
Multidisciplinary management of head and neck sarcomas2005
Dr Charles Kelly
Symptom control and quality of life in people with lung cancer: A randomised trial of two palliative radiotherapy fractionation schedules2005
Dr Charles Kelly
Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy - A multicenter open randomized phase III study2005
Dr Nick Steen
Dr Charles Kelly
Andrew Welch
Dr David Meikle
Emerita Professor Janet Wilson
et al.
Optimizing the assessment of quality of life after laryngeal cancer treatment2004
Sophia Stavrakakis
Neil McLean
Peter Hodgkinson
Dr Charles Kelly
Microvascular histopathology in head and neck oncology2003
Neil McLean
Dr Charles Kelly
Head and neck oncology: the UK experience. Who is publishing what?2002
Dr Shaheel Chummun
Neil McLean
Dr Charles Kelly
Dr Peter Dawes
Dr David Meikle
et al.
Adenoid cystic carcinoma of the head and neck2001
Dr Charles Kelly
Result of two randomized trials comparing nolatrexed (Thymitaq (TM)) versus methotrexate in patients with recurrent head and neck cancer2001
Neil McLean
Dr Charles Kelly
Cutaneous metastasis to the head and neck from colonic carcinoma2000
Neil McLean
Dr Charles Kelly
Head and neck skin involvement by non-cutaneous head and neck cancers: Free flap reconstruction2000
Emeritus Professor Roger Francis
Dr Alexis Chuck
Dr Paul Crook
Dr Terence Daymond
Dr John Fordham
et al.
Management of osteoporosis in patients with hip fractures2000
Dr Charles Kelly
Neil McLean
Trans-osseous passage of head and neck brachytherapy tubes2000
Dr Ramesh Rajentheran
Dr Charles Kelly
Malcolm Reed
Dr Anita Nolan
Malignant transformation of oral lichen planus1999
Professor John Lunec
Emerita Professor Janet Wilson
Dr Charles Kelly
Expression of cyclin dependent kinase inhibitors in laryngeal cancer1998
Neil McLean
Dr Charles Kelly
Dr Andrew Chippindale
Malignant tumours of the parotid gland: A 12-year review1997
Emeritus Professor Andy Hall
Dr Charles Kelly
Exercise testing soon after myocardial infarction: its relation to course and outcome at one year in patients aged less than 55 years1989